Jordi Bruix

Suggest Changes
Learn More
  • Josep M Llovet, Sergio Ricci, +21 authors Jordi Bruix
  • The New England journal of medicine
  • 2008
BACKGROUND No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular(More)